Michael Carulli
Förmögenhet: 89 356 $ per 2026-08-31
Förmögenhet: 89 356 $ per 2026-08-31
Michael Carulli is currently Chief Financial Officer at PMV Pharmaceuticals, Inc. since 2024.
Formerly, Mr. Carulli was Executive Director-R&D Financial Planning at Bristol Myers Squibb Co. Mr. Carulli earned an MBA from Fordham University and completed undergraduate studies at Siena College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-05 | 73 848 ( 0,14 % ) | 89 356 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2024-01-05 |
| Företag | Position | Slut |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Siena College
Siena College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån